Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Revenue

Rhythm Pharmaceuticals had revenue of $71.26M in the quarter ending June 30, 2026, with 46.91% growth. This brings the company's total for the last twelve months to $239.92M, up 53.51% year-over-year. In the year 2025, Rhythm Pharmaceuticals had annual revenue of $189.76M with 45.83% growth. That makes Rhythm Pharmaceuticals the 16,160th largest company in the world by revenue and 2,763rd in the United States.

• Revenue (ttm): $239.92M
• Revenue Growth: +53.51%
• P/S Ratio: 26.82
• Revenue / Employee: $579,512
• Employees: 414
• Market Cap: 6.43B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Product Revenue, Net 194.77M 100.0%

By Geography

Chart

• United States 133.55M 68.6%
• Other 61.22M 31.4%

Fiscal year ended Dec 31, 2025 See the full Rhythm Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	189.76M	59.63M	45.83%
Dec 31, 2024	130.13M	52.70M	68.06%
Dec 31, 2023	77.43M	53.79M	227.56%
Dec 31, 2022	23.64M	20.48M	649.46%
Dec 31, 2021	3.15M	-	-

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Aug 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error